Structure

Physi-Chem Properties

Molecular Weight:  330.07
Volume:  311.439
LogP:  2.81
LogD:  2.766
LogS:  -4.26
# Rotatable Bonds:  2
TPSA:  94.45
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  4
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.871
Synthetic Accessibility Score:  3.125
Fsp3:  0.235
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.872
MDCK Permeability:  2.487856909283437e-05
Pgp-inhibitor:  0.008
Pgp-substrate:  0.01
Human Intestinal Absorption (HIA):  0.005
20% Bioavailability (F20%):  0.005
30% Bioavailability (F30%):  0.024

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.026
Plasma Protein Binding (PPB):  98.84293365478516%
Volume Distribution (VD):  0.647
Pgp-substrate:  1.8293884992599487%

ADMET: Metabolism

CYP1A2-inhibitor:  0.964
CYP1A2-substrate:  0.745
CYP2C19-inhibitor:  0.916
CYP2C19-substrate:  0.166
CYP2C9-inhibitor:  0.781
CYP2C9-substrate:  0.898
CYP2D6-inhibitor:  0.947
CYP2D6-substrate:  0.877
CYP3A4-inhibitor:  0.93
CYP3A4-substrate:  0.319

ADMET: Excretion

Clearance (CL):  15.704
Half-life (T1/2):  0.341

ADMET: Toxicity

hERG Blockers:  0.053
Human Hepatotoxicity (H-HT):  0.086
Drug-inuced Liver Injury (DILI):  0.598
AMES Toxicity:  0.3
Rat Oral Acute Toxicity:  0.386
Maximum Recommended Daily Dose:  0.838
Skin Sensitization:  0.653
Carcinogencity:  0.732
Eye Corrosion:  0.003
Eye Irritation:  0.409
Respiratory Toxicity:  0.336

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469575

Natural Product ID:  NPC469575
Common Name*:   (3R,3S)-Onogenin
IUPAC Name:   5,7-dihydroxy-3-(6-methoxy-1,3-benzodioxol-5-yl)-2,3-dihydrochromen-4-one
Synonyms:   (3R,3S)-Onogenin
Standard InCHIKey:  MNXNLFUKHPLPES-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C17H14O7/c1-21-12-5-14-13(23-7-24-14)4-9(12)10-6-22-15-3-8(18)2-11(19)16(15)17(10)20/h2-5,10,18-19H,6-7H2,1H3
SMILES:  COC1=CC2=C(C=C1C3COC4=CC(=CC(=C4C3=O)O)O)OCO2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1088034
PubChem CID:   46881084
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002586] O-methylated isoflavonoids
          • [CHEMONTID:0002604] 2'-O-methylated isoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14114 Dalbergia parviflora Species Fabaceae Eukaryota heartwood n.a. n.a. PMID[19928832]
NPO14114 Dalbergia parviflora Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT396 Cell Line T47D Homo sapiens Activity = 5.6 uM PMID[479116]
NPT396 Cell Line T47D Homo sapiens Activity = 1.9 uM PMID[479116]
NPT83 Cell Line MCF7 Homo sapiens Activity > 100.0 uM PMID[479116]
NPT396 Cell Line T47D Homo sapiens Activity = 8.1 uM PMID[479116]
NPT396 Cell Line T47D Homo sapiens Activity = 1.0 uM PMID[479116]
NPT83 Cell Line MCF7 Homo sapiens Activity = 9.4 uM PMID[479116]
NPT83 Cell Line MCF7 Homo sapiens Activity = 4.2 uM PMID[479116]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469575 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9563 High Similarity NPC223375
0.9563 High Similarity NPC475825
0.9554 High Similarity NPC470178
0.9484 High Similarity NPC167595
0.9484 High Similarity NPC258644
0.9427 High Similarity NPC162668
0.9423 High Similarity NPC215375
0.9423 High Similarity NPC62518
0.9375 High Similarity NPC42892
0.9367 High Similarity NPC478199
0.9359 High Similarity NPC181960
0.9359 High Similarity NPC469584
0.9355 High Similarity NPC472909
0.9313 High Similarity NPC113093
0.9308 High Similarity NPC273959
0.9304 High Similarity NPC295009
0.9304 High Similarity NPC260640
0.929 High Similarity NPC244371
0.9286 High Similarity NPC117579
0.9245 High Similarity NPC125991
0.9241 High Similarity NPC285973
0.9241 High Similarity NPC225624
0.9236 High Similarity NPC222814
0.9236 High Similarity NPC472910
0.9236 High Similarity NPC472911
0.9236 High Similarity NPC96167
0.9236 High Similarity NPC472914
0.9236 High Similarity NPC472913
0.9236 High Similarity NPC245758
0.9231 High Similarity NPC18954
0.9231 High Similarity NPC31018
0.9231 High Similarity NPC255807
0.9231 High Similarity NPC37392
0.9226 High Similarity NPC292460
0.9221 High Similarity NPC179183
0.9198 High Similarity NPC472381
0.9198 High Similarity NPC472383
0.9187 High Similarity NPC475985
0.9172 High Similarity NPC235165
0.9172 High Similarity NPC255106
0.9167 High Similarity NPC472915
0.9167 High Similarity NPC280937
0.9161 High Similarity NPC149614
0.9152 High Similarity NPC156635
0.9141 High Similarity NPC183357
0.9141 High Similarity NPC22195
0.9141 High Similarity NPC21190
0.9141 High Similarity NPC224462
0.9141 High Similarity NPC105511
0.9141 High Similarity NPC44558
0.9141 High Similarity NPC212748
0.9136 High Similarity NPC93099
0.9136 High Similarity NPC76482
0.913 High Similarity NPC326520
0.9119 High Similarity NPC475886
0.9119 High Similarity NPC269906
0.9119 High Similarity NPC474287
0.9114 High Similarity NPC129684
0.9114 High Similarity NPC165977
0.9114 High Similarity NPC99597
0.9114 High Similarity NPC241904
0.9114 High Similarity NPC162869
0.9114 High Similarity NPC210084
0.9114 High Similarity NPC475267
0.9114 High Similarity NPC300727
0.9114 High Similarity NPC217677
0.9114 High Similarity NPC299520
0.9114 High Similarity NPC48208
0.9114 High Similarity NPC474990
0.9114 High Similarity NPC474208
0.9114 High Similarity NPC474836
0.9114 High Similarity NPC156057
0.9108 High Similarity NPC2928
0.9103 High Similarity NPC199100
0.9103 High Similarity NPC148497
0.9103 High Similarity NPC101996
0.9103 High Similarity NPC180234
0.9103 High Similarity NPC120537
0.9103 High Similarity NPC104728
0.9103 High Similarity NPC35544
0.9103 High Similarity NPC153008
0.9103 High Similarity NPC260979
0.9097 High Similarity NPC306821
0.9097 High Similarity NPC338131
0.9097 High Similarity NPC234152
0.9091 High Similarity NPC236327
0.9091 High Similarity NPC472607
0.9091 High Similarity NPC290304
0.9085 High Similarity NPC307518
0.9085 High Similarity NPC260263
0.9085 High Similarity NPC267254
0.9085 High Similarity NPC48773
0.9085 High Similarity NPC205076
0.9085 High Similarity NPC472386
0.908 High Similarity NPC201292
0.908 High Similarity NPC95855
0.908 High Similarity NPC471457
0.908 High Similarity NPC226294
0.908 High Similarity NPC186807
0.908 High Similarity NPC170675
0.908 High Similarity NPC93337
0.908 High Similarity NPC45638
0.908 High Similarity NPC105025
0.908 High Similarity NPC469931
0.908 High Similarity NPC183036
0.908 High Similarity NPC112755
0.908 High Similarity NPC211309
0.908 High Similarity NPC58053
0.908 High Similarity NPC475942
0.908 High Similarity NPC471287
0.908 High Similarity NPC210042
0.9074 High Similarity NPC128293
0.9074 High Similarity NPC170245
0.9068 High Similarity NPC110257
0.9068 High Similarity NPC94777
0.9062 High Similarity NPC266314
0.9062 High Similarity NPC474351
0.9062 High Similarity NPC475883
0.9062 High Similarity NPC470756
0.9062 High Similarity NPC474187
0.9062 High Similarity NPC474186
0.9062 High Similarity NPC94155
0.9057 High Similarity NPC476242
0.9057 High Similarity NPC152904
0.9051 High Similarity NPC45131
0.9051 High Similarity NPC155063
0.9051 High Similarity NPC274730
0.9051 High Similarity NPC472916
0.9045 High Similarity NPC88645
0.9045 High Similarity NPC292214
0.9045 High Similarity NPC271779
0.9045 High Similarity NPC167091
0.9045 High Similarity NPC57211
0.9045 High Similarity NPC478213
0.9045 High Similarity NPC206238
0.9045 High Similarity NPC469550
0.9038 High Similarity NPC171010
0.9038 High Similarity NPC208043
0.9038 High Similarity NPC226973
0.9038 High Similarity NPC279061
0.9036 High Similarity NPC257714
0.9032 High Similarity NPC238366
0.9032 High Similarity NPC328119
0.903 High Similarity NPC239549
0.903 High Similarity NPC51774
0.903 High Similarity NPC236191
0.9024 High Similarity NPC471416
0.9024 High Similarity NPC34287
0.9024 High Similarity NPC474434
0.902 High Similarity NPC472917
0.9018 High Similarity NPC471288
0.9018 High Similarity NPC146792
0.9018 High Similarity NPC135345
0.9018 High Similarity NPC58716
0.9018 High Similarity NPC45618
0.9012 High Similarity NPC475738
0.9012 High Similarity NPC25361
0.9012 High Similarity NPC165720
0.9006 High Similarity NPC127782
0.9006 High Similarity NPC300537
0.9006 High Similarity NPC81679
0.9 High Similarity NPC228785
0.9 High Similarity NPC263449
0.9 High Similarity NPC14353
0.9 High Similarity NPC56085
0.8994 High Similarity NPC36852
0.8994 High Similarity NPC78225
0.8994 High Similarity NPC220462
0.8994 High Similarity NPC223787
0.8994 High Similarity NPC262286
0.8994 High Similarity NPC108456
0.8987 High Similarity NPC478238
0.8987 High Similarity NPC213622
0.8982 High Similarity NPC67302
0.8981 High Similarity NPC239128
0.8981 High Similarity NPC187498
0.8981 High Similarity NPC219582
0.8981 High Similarity NPC71334
0.8981 High Similarity NPC52623
0.8981 High Similarity NPC156222
0.8981 High Similarity NPC301123
0.8981 High Similarity NPC275836
0.8981 High Similarity NPC188203
0.8981 High Similarity NPC57030
0.8981 High Similarity NPC301323
0.8981 High Similarity NPC302950
0.8981 High Similarity NPC83508
0.8981 High Similarity NPC68882
0.8981 High Similarity NPC293183
0.8981 High Similarity NPC198826
0.8981 High Similarity NPC161277
0.8981 High Similarity NPC39007
0.8981 High Similarity NPC100887
0.8981 High Similarity NPC120163
0.8981 High Similarity NPC212678
0.8981 High Similarity NPC162313
0.8981 High Similarity NPC256283
0.8981 High Similarity NPC131624
0.8981 High Similarity NPC222830
0.8981 High Similarity NPC236637

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469575 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9018 High Similarity NPD3818 Discontinued
0.8981 High Similarity NPD1934 Approved
0.8924 High Similarity NPD2801 Approved
0.8882 High Similarity NPD5494 Approved
0.8795 High Similarity NPD7074 Phase 3
0.875 High Similarity NPD4338 Clinical (unspecified phase)
0.8735 High Similarity NPD7054 Approved
0.8696 High Similarity NPD3882 Suspended
0.8688 High Similarity NPD2393 Clinical (unspecified phase)
0.8683 High Similarity NPD7472 Approved
0.8529 High Similarity NPD7808 Phase 3
0.8528 High Similarity NPD4381 Clinical (unspecified phase)
0.8521 High Similarity NPD6797 Phase 2
0.8471 Intermediate Similarity NPD1511 Approved
0.8471 Intermediate Similarity NPD7251 Discontinued
0.8443 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD6166 Phase 2
0.8405 Intermediate Similarity NPD3817 Phase 2
0.8365 Intermediate Similarity NPD1512 Approved
0.8354 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8284 Intermediate Similarity NPD7473 Discontinued
0.8269 Intermediate Similarity NPD1549 Phase 2
0.8256 Intermediate Similarity NPD6559 Discontinued
0.8214 Intermediate Similarity NPD6232 Discontinued
0.8199 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD5844 Phase 1
0.8187 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD37 Approved
0.8155 Intermediate Similarity NPD1247 Approved
0.8155 Intermediate Similarity NPD7199 Phase 2
0.8144 Intermediate Similarity NPD6234 Discontinued
0.8133 Intermediate Similarity NPD4967 Phase 2
0.8133 Intermediate Similarity NPD4965 Approved
0.8133 Intermediate Similarity NPD4966 Approved
0.8121 Intermediate Similarity NPD7819 Suspended
0.8121 Intermediate Similarity NPD1465 Phase 2
0.8084 Intermediate Similarity NPD7075 Discontinued
0.8077 Intermediate Similarity NPD1510 Phase 2
0.8072 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8059 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.8049 Intermediate Similarity NPD4380 Phase 2
0.8038 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD2800 Approved
0.7976 Intermediate Similarity NPD3749 Approved
0.7963 Intermediate Similarity NPD2533 Approved
0.7963 Intermediate Similarity NPD2532 Approved
0.7963 Intermediate Similarity NPD2534 Approved
0.7953 Intermediate Similarity NPD3926 Phase 2
0.7941 Intermediate Similarity NPD6959 Discontinued
0.7935 Intermediate Similarity NPD1240 Approved
0.7929 Intermediate Similarity NPD919 Approved
0.7919 Intermediate Similarity NPD7228 Approved
0.7911 Intermediate Similarity NPD2796 Approved
0.7901 Intermediate Similarity NPD6799 Approved
0.7892 Intermediate Similarity NPD7411 Suspended
0.7886 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7865 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7857 Intermediate Similarity NPD5402 Approved
0.7834 Intermediate Similarity NPD1607 Approved
0.7831 Intermediate Similarity NPD6599 Discontinued
0.7816 Intermediate Similarity NPD3751 Discontinued
0.7771 Intermediate Similarity NPD1933 Approved
0.7747 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD6801 Discontinued
0.7735 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7716 Intermediate Similarity NPD3750 Approved
0.7711 Intermediate Similarity NPD1653 Approved
0.7707 Intermediate Similarity NPD943 Approved
0.7701 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7688 Intermediate Similarity NPD2935 Discontinued
0.7688 Intermediate Similarity NPD3787 Discontinued
0.7658 Intermediate Similarity NPD230 Phase 1
0.7658 Intermediate Similarity NPD447 Suspended
0.7651 Intermediate Similarity NPD920 Approved
0.764 Intermediate Similarity NPD2344 Approved
0.764 Intermediate Similarity NPD7685 Pre-registration
0.7613 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD7768 Phase 2
0.7595 Intermediate Similarity NPD1613 Approved
0.7595 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD1551 Phase 2
0.7578 Intermediate Similarity NPD6099 Approved
0.7578 Intermediate Similarity NPD6100 Approved
0.7564 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD8312 Approved
0.7556 Intermediate Similarity NPD8313 Approved
0.7546 Intermediate Similarity NPD1243 Approved
0.7542 Intermediate Similarity NPD7240 Approved
0.753 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD5711 Approved
0.7486 Intermediate Similarity NPD5710 Approved
0.7468 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.746 Intermediate Similarity NPD6780 Approved
0.746 Intermediate Similarity NPD6779 Approved
0.746 Intermediate Similarity NPD6782 Approved
0.746 Intermediate Similarity NPD6776 Approved
0.746 Intermediate Similarity NPD6781 Approved
0.746 Intermediate Similarity NPD6778 Approved
0.746 Intermediate Similarity NPD6777 Approved
0.746 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD3226 Approved
0.7455 Intermediate Similarity NPD2309 Approved
0.744 Intermediate Similarity NPD5403 Approved
0.7439 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD5401 Approved
0.7423 Intermediate Similarity NPD2346 Discontinued
0.741 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7407 Intermediate Similarity NPD2799 Discontinued
0.7407 Intermediate Similarity NPD3748 Approved
0.7394 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD4628 Phase 3
0.7353 Intermediate Similarity NPD7458 Discontinued
0.7344 Intermediate Similarity NPD7697 Approved
0.7344 Intermediate Similarity NPD7698 Approved
0.7344 Intermediate Similarity NPD7435 Discontinued
0.7344 Intermediate Similarity NPD7696 Phase 3
0.7342 Intermediate Similarity NPD4908 Phase 1
0.7338 Intermediate Similarity NPD1610 Phase 2
0.7337 Intermediate Similarity NPD8434 Phase 2
0.7333 Intermediate Similarity NPD8151 Discontinued
0.7325 Intermediate Similarity NPD2798 Approved
0.7322 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7306 Intermediate Similarity NPD7871 Phase 2
0.7306 Intermediate Similarity NPD7870 Phase 2
0.7303 Intermediate Similarity NPD2403 Approved
0.7301 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD3027 Phase 3
0.7293 Intermediate Similarity NPD5953 Discontinued
0.7292 Intermediate Similarity NPD5006 Approved
0.7292 Intermediate Similarity NPD5005 Approved
0.7288 Intermediate Similarity NPD7229 Phase 3
0.7284 Intermediate Similarity NPD6651 Approved
0.7278 Intermediate Similarity NPD7286 Phase 2
0.7278 Intermediate Similarity NPD2861 Phase 2
0.7259 Intermediate Similarity NPD7783 Phase 2
0.7259 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.725 Intermediate Similarity NPD2313 Discontinued
0.7247 Intermediate Similarity NPD5242 Approved
0.7241 Intermediate Similarity NPD5353 Approved
0.7202 Intermediate Similarity NPD6823 Phase 2
0.7196 Intermediate Similarity NPD6535 Approved
0.7196 Intermediate Similarity NPD6534 Approved
0.7194 Intermediate Similarity NPD7701 Phase 2
0.7179 Intermediate Similarity NPD1608 Approved
0.7173 Intermediate Similarity NPD4420 Approved
0.7172 Intermediate Similarity NPD7801 Approved
0.717 Intermediate Similarity NPD9494 Approved
0.716 Intermediate Similarity NPD7390 Discontinued
0.7152 Intermediate Similarity NPD1203 Approved
0.7143 Intermediate Similarity NPD6190 Approved
0.7143 Intermediate Similarity NPD7584 Approved
0.7143 Intermediate Similarity NPD3268 Approved
0.7135 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD6674 Discontinued
0.7121 Intermediate Similarity NPD7874 Approved
0.7121 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.712 Intermediate Similarity NPD7549 Discontinued
0.7117 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD3705 Approved
0.7115 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.711 Intermediate Similarity NPD7028 Phase 2
0.7108 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD4363 Phase 3
0.7105 Intermediate Similarity NPD4360 Phase 2
0.7091 Intermediate Similarity NPD7033 Discontinued
0.7086 Intermediate Similarity NPD8455 Phase 2
0.7083 Intermediate Similarity NPD7700 Phase 2
0.7083 Intermediate Similarity NPD7699 Phase 2
0.7074 Intermediate Similarity NPD4287 Approved
0.7069 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD4361 Phase 2
0.7068 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD8150 Discontinued
0.7044 Intermediate Similarity NPD2797 Approved
0.7037 Intermediate Similarity NPD3764 Approved
0.7029 Intermediate Similarity NPD6844 Discontinued
0.7025 Intermediate Similarity NPD4749 Approved
0.7024 Intermediate Similarity NPD2654 Approved
0.7019 Intermediate Similarity NPD6832 Phase 2
0.7018 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD6355 Discontinued
0.7006 Intermediate Similarity NPD7266 Discontinued
0.7006 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.699 Remote Similarity NPD7680 Approved
0.6987 Remote Similarity NPD17 Approved
0.6982 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6982 Remote Similarity NPD4110 Phase 3
0.6971 Remote Similarity NPD6386 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data